Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Chu

Showing results (81-90 of 130) with videos related to

Pageof 13
Sort By:
Technology in Cancer Research & Treatment|September 10, 2015
Computed Tomography Evaluation of Density Following Stereotactic Body Radiation Therapy of Nonspine Bone MetastasesRachel McDonald, Linda Probyn, Ian Poon, et al.
International Journal of Radiation Oncology, Biology, Physics|November 5, 2015
Tumor Response After Stereotactic Body Radiation Therapy to Nonspine Bone Metastases: An Evaluation of Response CriteriaRachel McDonald, Linda Probyn, Ian Poon, et al.
International Journal of Radiation Oncology, Biology, Physics|March 31, 2016
Predictive Parameters of Symptomatic Hematochezia Following 5-Fraction Gantry-Based SABR in Prostate CancerHima Bindu Musunuru, Melanie Davidson, Patrick Cheung, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 6, 2023
Predictors of pathologic fracture and local recurrence following stereotactic body radiation therapy to 505 non-spine bone metastasesEric K Nguyen, Renee Korol, Saher Ali, et al.
Neurotrauma Reports|March 12, 2026
Spinal Cord Injuries Secondary to Mountain Biking Accidents - A Cause for National AlarmWilliam Chu Kwan, Pedram Laghaei, Harsh Kahlon, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 25, 2003
Comprehensive assessment of candidate genes and serological markers for the detection of prostate cancerRobert K Nam, William W Zhang, John Trachtenberg, et al.
International Journal of Radiation Oncology, Biology, Physics|October 12, 2021
Gantry-Based 5-Fraction Elective Nodal Irradiation in Unfavorable-Risk Prostate Cancer: Outcomes From 2 Prospective Studies Comparing SABR Boost With MR Dose-Painted HDR Brachytherapy BoostHima Bindu Musunuru, Patrick Cheung, Danny Vesprini, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 5, 2021
Stereotactic pelvic radiotherapy with HDR boost for dose escalation in intermediate and high-risk prostate cancer (SPARE): Efficacy, toxicity and quality of lifeHima Bindu Musunuru, Patrick Cheung, Danny Vesprini, et al.
International Journal of Radiation Oncology, Biology, Physics|November 18, 2023
Randomized Trial of Concomitant Hypofractionated Intensity Modulated Radiation Therapy Boost Versus Conventionally Fractionated Intensity Modulated Radiation Therapy Boost for Localized High-Risk Prostate Cancer (pHART2-RCT)Rachel M Glicksman, Andrew Loblaw, Gerard Morton, et al.
Clinical and Translational Radiation Oncology|September 25, 2024
Elective pelvic nodal irradiation in the setting of ultrahypofractionated versus moderately hypofractionated and conventionally fractionated radiotherapy for prostate cancer: Outcomes from 3 prospective clinical trialsRachel M Glicksman, Andrew Loblaw, Gerard Morton, et al.
Pageof 13

Showing results (81-90 of 130) with videos related to

Sort By:
Pageof 13
Technology in Cancer Research & Treatment|September 10, 2015
Computed Tomography Evaluation of Density Following Stereotactic Body Radiation Therapy of Nonspine Bone MetastasesRachel McDonald, Linda Probyn, Ian Poon, et al.
International Journal of Radiation Oncology, Biology, Physics|November 5, 2015
Tumor Response After Stereotactic Body Radiation Therapy to Nonspine Bone Metastases: An Evaluation of Response CriteriaRachel McDonald, Linda Probyn, Ian Poon, et al.
International Journal of Radiation Oncology, Biology, Physics|March 31, 2016
Predictive Parameters of Symptomatic Hematochezia Following 5-Fraction Gantry-Based SABR in Prostate CancerHima Bindu Musunuru, Melanie Davidson, Patrick Cheung, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 6, 2023
Predictors of pathologic fracture and local recurrence following stereotactic body radiation therapy to 505 non-spine bone metastasesEric K Nguyen, Renee Korol, Saher Ali, et al.
Neurotrauma Reports|March 12, 2026
Spinal Cord Injuries Secondary to Mountain Biking Accidents - A Cause for National AlarmWilliam Chu Kwan, Pedram Laghaei, Harsh Kahlon, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 25, 2003
Comprehensive assessment of candidate genes and serological markers for the detection of prostate cancerRobert K Nam, William W Zhang, John Trachtenberg, et al.
International Journal of Radiation Oncology, Biology, Physics|October 12, 2021
Gantry-Based 5-Fraction Elective Nodal Irradiation in Unfavorable-Risk Prostate Cancer: Outcomes From 2 Prospective Studies Comparing SABR Boost With MR Dose-Painted HDR Brachytherapy BoostHima Bindu Musunuru, Patrick Cheung, Danny Vesprini, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 5, 2021
Stereotactic pelvic radiotherapy with HDR boost for dose escalation in intermediate and high-risk prostate cancer (SPARE): Efficacy, toxicity and quality of lifeHima Bindu Musunuru, Patrick Cheung, Danny Vesprini, et al.
International Journal of Radiation Oncology, Biology, Physics|November 18, 2023
Randomized Trial of Concomitant Hypofractionated Intensity Modulated Radiation Therapy Boost Versus Conventionally Fractionated Intensity Modulated Radiation Therapy Boost for Localized High-Risk Prostate Cancer (pHART2-RCT)Rachel M Glicksman, Andrew Loblaw, Gerard Morton, et al.
Clinical and Translational Radiation Oncology|September 25, 2024
Elective pelvic nodal irradiation in the setting of ultrahypofractionated versus moderately hypofractionated and conventionally fractionated radiotherapy for prostate cancer: Outcomes from 3 prospective clinical trialsRachel M Glicksman, Andrew Loblaw, Gerard Morton, et al.
Pageof 13